文献速递生殖医学妇科

比较医学辅助与非医学辅助受孕的早期妊娠丢失药物管理成功的回顾性队列研究

Retrospective cohort study comparing success of medical management of early pregnancy loss in pregnancies conceived with and without medical assistance.
PubMed 文献 · Fertil Steril · 2024-01-09

该回顾性队列研究纳入2013年6月至2021年7月间孕13周以下早期妊娠丢失且接受米非司酮200 mg口服联合米索前列醇800 mcg阴道用药的930例女性,其中99例(11%)为体外受精(IVF)后妊娠。总体治疗成功率为89%,不同受孕方式(89% vs. 89%)及胚胎移植类型(新鲜89% vs. 冷冻89%)间无统计学显著差异;仅超声下较低孕周独立预测治疗成功(β=-0.333,OR 0.717)。

要点

  • 米非司酮200 mg口服联合米索前列醇800 mcg阴道用药的总体成功率为89%。
  • 非医学辅助受孕与IVF后妊娠的成功率无统计学显著差异(89% vs. 89%)。
  • 仅超声下较低孕周独立预测治疗成功(β=-0.333,OR 0.717)。

核心结论

  • 早期妊娠丢失采用米非司酮联合米索前列醇药物管理在非医学辅助受孕和IVF后妊娠中均为高成功率且能及时完成流产的治疗选择。

研究设计与样本

  • 回顾性队列研究,纳入2013年6月至2021年7月间孕13周以下早期妊娠丢失且接受米非司酮200 mg口服联合米索前列醇800 mcg阴道用药的女性930例,其中99例(11%)为IVF后妊娠。

主要发现

  • 总体治疗成功率为89%,非医学辅助受孕与IVF后妊娠成功率无统计学显著差异(89% vs. 89%)。
  • 新鲜胚胎移植与冷冻胚胎移植的IVF妊娠成功率无统计学显著差异(89% vs. 89%)。
  • 仅超声下较低孕周独立预测治疗成功(β=-0.333,OR 0.717)。
  • 首次组织排出的平均时间为5.0 ± 2.1小时。
  • 666例(72%)在用药当日妊娠解除,额外110例在1周随访时解除,另有74例在≥4周超声后解除。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the success rates of medical management using a combined mifepristone and misoprostol protocol in cases of early pregnancy loss (EPL) between women who conceived without medical assistance and those who conceived through in vitro fertilization (IVF), after fresh or frozen embryo transfer, and evaluate for the predictive factors of success, time to first passage of tissue, and time to complete resolution of pregnancy. DESIGN: Retrospective cohort study. SETTING: University hospital. PATIENT(S): Women who presented with EPL below 13 weeks of gestation between June 2013 and July 2021 who were managed medically with mifepristone 200 mg orally and misoprostol 800 mcg vaginally were included in the study. INTERVENTION(S): Medical management with mifepristone and misoprostol; conception without medical assistance vs. post-IVF, after fresh or frozen embryo transfer. MAIN OUTCOME MEASURE(S): We evaluated overall success and performed subgroup analysis according to the mode of conception and compared fresh vs. frozen-thawed embryo transfers for IVF pregnancies. In all groups, we also calculated success according to gestational age and compared the time to first passage of tissue. The potential predictive factors of treatment success were analyzed. The side effects and complications of treatment were recorded. RESULT(S): A total of 930 women were included in the study, 99 (11%) of whom achieved pregnancy after IVF. The overall success of medical treatment was 89% with no statistically significant difference according to the mode of conception (89% vs. 89%) or type of transfer (fresh 89% vs. frozen 89%). Only lower gestational age by sonography was independently predictive of treatment success, showing a negative regression coefficient of β = -0.333 and an odds ratio of 0.717. The mean time to first passage of tissue was 5.0 ± 2.1 hours. Altogether, 666 women (72%) showed pregnancy resolution on the day of medication administration, an additional 110 women at 1-week follow-up, and a further 74 women after ≥4 weeks on ultrasound. CONCLUSION(S): Medical management of EPL with mifepristone and misoprostol is a highly successful treatment option that results in completed abortion in a timely fashion in both pregnancies conceived without medical assistance and those conceived after IVF.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Colleselli-Türtscher V, Hafenmayr M, Ciresa-König A, et al. Retrospective cohort study comparing success of medical management of early pregnancy loss in pregnancies conceived with and without medical assistance. Fertil Steril. 2024. PMID: 38211763. doi:10.1016/j.fertnstert.2024.01.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。